ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lipid Nanoparticles (LNPs) CDMO Service Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17T16168
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Lipid Nanoparticles LNPs CDMO Service Market Research Report 2023
BUY CHAPTERS

Global Lipid Nanoparticles (LNPs) CDMO Service Market Research Report 2025

Code: QYRE-Auto-17T16168
Report
May 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Samsung Biologics
Hanmi Pharmaceutical
Catalent Biologics
FUJIFILM Pharmaceuticals
CordenPharma
eTheRNA
Esco Aster
Recipharm
Yuantai Biological Technology
GenScript Biotechnology
Wuxi Biologics
ST Pharm
Evonik
Lonza
Rentschler Biopharma

Lipid Nanoparticles (LNPs) CDMO Service Market

The global market for Lipid Nanoparticles (LNPs) CDMO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Lipid Nanoparticles (LNPs) CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lipid Nanoparticles (LNPs) CDMO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Lipid Nanoparticles (LNPs) CDMO Service in Vaccines and Drugs is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Lipid Nanoparticles (LNPs) CDMO Service include Evonik, Lonza, Rentschler Biopharma, Samsung Biologics, Hanmi Pharmaceutical, Catalent Biologics, FUJIFILM Pharmaceuticals, CordenPharma, ST Pharm, eTheRNA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lipid Nanoparticles (LNPs) CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Nanoparticles (LNPs) CDMO Service.
The Lipid Nanoparticles (LNPs) CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lipid Nanoparticles (LNPs) CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lipid Nanoparticles (LNPs) CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Lipid Nanoparticles (LNPs) CDMO Service Market Report

Report Metric Details
Report Name Lipid Nanoparticles (LNPs) CDMO Service Market
Segment by Type
  • mRNA-LNP CDMO
  • siRNA-LNP CDMO
  • pDNA-LNP CDMO
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Evonik, Lonza, Rentschler Biopharma, Samsung Biologics, Hanmi Pharmaceutical, Catalent Biologics, FUJIFILM Pharmaceuticals, CordenPharma, ST Pharm, eTheRNA, Esco Aster, Recipharm, Yuantai Biological Technology, GenScript Biotechnology, WuXi Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Lipid Nanoparticles (LNPs) CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lipid Nanoparticles (LNPs) CDMO Service Market report?

Ans: The main players in the Lipid Nanoparticles (LNPs) CDMO Service Market are Evonik, Lonza, Rentschler Biopharma, Samsung Biologics, Hanmi Pharmaceutical, Catalent Biologics, FUJIFILM Pharmaceuticals, CordenPharma, ST Pharm, eTheRNA, Esco Aster, Recipharm, Yuantai Biological Technology, GenScript Biotechnology, WuXi Biologics

What are the Application segmentation covered in the Lipid Nanoparticles (LNPs) CDMO Service Market report?

Ans: The Applications covered in the Lipid Nanoparticles (LNPs) CDMO Service Market report are Vaccines and Drugs, Diagnostics and Medical Imaging, Nanotherapeutics, Others

What are the Type segmentation covered in the Lipid Nanoparticles (LNPs) CDMO Service Market report?

Ans: The Types covered in the Lipid Nanoparticles (LNPs) CDMO Service Market report are mRNA-LNP CDMO, siRNA-LNP CDMO, pDNA-LNP CDMO, Others

Recommended Reports

Lipid Nanoparticle Markets

CDMO Services

Gene & Cell Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lipid Nanoparticles (LNPs) CDMO Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 mRNA-LNP CDMO
1.2.3 siRNA-LNP CDMO
1.2.4 pDNA-LNP CDMO
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lipid Nanoparticles (LNPs) CDMO Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Vaccines and Drugs
1.3.3 Diagnostics and Medical Imaging
1.3.4 Nanotherapeutics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lipid Nanoparticles (LNPs) CDMO Service Market Perspective (2020-2031)
2.2 Global Lipid Nanoparticles (LNPs) CDMO Service Growth Trends by Region
2.2.1 Global Lipid Nanoparticles (LNPs) CDMO Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lipid Nanoparticles (LNPs) CDMO Service Historic Market Size by Region (2020-2025)
2.2.3 Lipid Nanoparticles (LNPs) CDMO Service Forecasted Market Size by Region (2026-2031)
2.3 Lipid Nanoparticles (LNPs) CDMO Service Market Dynamics
2.3.1 Lipid Nanoparticles (LNPs) CDMO Service Industry Trends
2.3.2 Lipid Nanoparticles (LNPs) CDMO Service Market Drivers
2.3.3 Lipid Nanoparticles (LNPs) CDMO Service Market Challenges
2.3.4 Lipid Nanoparticles (LNPs) CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lipid Nanoparticles (LNPs) CDMO Service Players by Revenue
3.1.1 Global Top Lipid Nanoparticles (LNPs) CDMO Service Players by Revenue (2020-2025)
3.1.2 Global Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Players (2020-2025)
3.2 Global Lipid Nanoparticles (LNPs) CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lipid Nanoparticles (LNPs) CDMO Service Revenue
3.4 Global Lipid Nanoparticles (LNPs) CDMO Service Market Concentration Ratio
3.4.1 Global Lipid Nanoparticles (LNPs) CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lipid Nanoparticles (LNPs) CDMO Service Revenue in 2024
3.5 Global Key Players of Lipid Nanoparticles (LNPs) CDMO Service Head office and Area Served
3.6 Global Key Players of Lipid Nanoparticles (LNPs) CDMO Service, Product and Application
3.7 Global Key Players of Lipid Nanoparticles (LNPs) CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lipid Nanoparticles (LNPs) CDMO Service Breakdown Data by Type
4.1 Global Lipid Nanoparticles (LNPs) CDMO Service Historic Market Size by Type (2020-2025)
4.2 Global Lipid Nanoparticles (LNPs) CDMO Service Forecasted Market Size by Type (2026-2031)
5 Lipid Nanoparticles (LNPs) CDMO Service Breakdown Data by Application
5.1 Global Lipid Nanoparticles (LNPs) CDMO Service Historic Market Size by Application (2020-2025)
5.2 Global Lipid Nanoparticles (LNPs) CDMO Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lipid Nanoparticles (LNPs) CDMO Service Market Size (2020-2031)
6.2 North America Lipid Nanoparticles (LNPs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2020-2025)
6.4 North America Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lipid Nanoparticles (LNPs) CDMO Service Market Size (2020-2031)
7.2 Europe Lipid Nanoparticles (LNPs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2020-2025)
7.4 Europe Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lipid Nanoparticles (LNPs) CDMO Service Market Size (2020-2031)
8.2 Asia-Pacific Lipid Nanoparticles (LNPs) CDMO Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lipid Nanoparticles (LNPs) CDMO Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Lipid Nanoparticles (LNPs) CDMO Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lipid Nanoparticles (LNPs) CDMO Service Market Size (2020-2031)
9.2 Latin America Lipid Nanoparticles (LNPs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2020-2025)
9.4 Latin America Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lipid Nanoparticles (LNPs) CDMO Service Market Size (2020-2031)
10.2 Middle East & Africa Lipid Nanoparticles (LNPs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Evonik
11.1.1 Evonik Company Details
11.1.2 Evonik Business Overview
11.1.3 Evonik Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.1.4 Evonik Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.1.5 Evonik Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.2.4 Lonza Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Rentschler Biopharma
11.3.1 Rentschler Biopharma Company Details
11.3.2 Rentschler Biopharma Business Overview
11.3.3 Rentschler Biopharma Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.3.4 Rentschler Biopharma Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.3.5 Rentschler Biopharma Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Details
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.4.4 Samsung Biologics Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.4.5 Samsung Biologics Recent Development
11.5 Hanmi Pharmaceutical
11.5.1 Hanmi Pharmaceutical Company Details
11.5.2 Hanmi Pharmaceutical Business Overview
11.5.3 Hanmi Pharmaceutical Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.5.4 Hanmi Pharmaceutical Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.5.5 Hanmi Pharmaceutical Recent Development
11.6 Catalent Biologics
11.6.1 Catalent Biologics Company Details
11.6.2 Catalent Biologics Business Overview
11.6.3 Catalent Biologics Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.6.4 Catalent Biologics Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.6.5 Catalent Biologics Recent Development
11.7 FUJIFILM Pharmaceuticals
11.7.1 FUJIFILM Pharmaceuticals Company Details
11.7.2 FUJIFILM Pharmaceuticals Business Overview
11.7.3 FUJIFILM Pharmaceuticals Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.7.4 FUJIFILM Pharmaceuticals Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.7.5 FUJIFILM Pharmaceuticals Recent Development
11.8 CordenPharma
11.8.1 CordenPharma Company Details
11.8.2 CordenPharma Business Overview
11.8.3 CordenPharma Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.8.4 CordenPharma Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.8.5 CordenPharma Recent Development
11.9 ST Pharm
11.9.1 ST Pharm Company Details
11.9.2 ST Pharm Business Overview
11.9.3 ST Pharm Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.9.4 ST Pharm Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.9.5 ST Pharm Recent Development
11.10 eTheRNA
11.10.1 eTheRNA Company Details
11.10.2 eTheRNA Business Overview
11.10.3 eTheRNA Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.10.4 eTheRNA Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.10.5 eTheRNA Recent Development
11.11 Esco Aster
11.11.1 Esco Aster Company Details
11.11.2 Esco Aster Business Overview
11.11.3 Esco Aster Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.11.4 Esco Aster Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.11.5 Esco Aster Recent Development
11.12 Recipharm
11.12.1 Recipharm Company Details
11.12.2 Recipharm Business Overview
11.12.3 Recipharm Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.12.4 Recipharm Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.12.5 Recipharm Recent Development
11.13 Yuantai Biological Technology
11.13.1 Yuantai Biological Technology Company Details
11.13.2 Yuantai Biological Technology Business Overview
11.13.3 Yuantai Biological Technology Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.13.4 Yuantai Biological Technology Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.13.5 Yuantai Biological Technology Recent Development
11.14 GenScript Biotechnology
11.14.1 GenScript Biotechnology Company Details
11.14.2 GenScript Biotechnology Business Overview
11.14.3 GenScript Biotechnology Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.14.4 GenScript Biotechnology Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.14.5 GenScript Biotechnology Recent Development
11.15 WuXi Biologics
11.15.1 WuXi Biologics Company Details
11.15.2 WuXi Biologics Business Overview
11.15.3 WuXi Biologics Lipid Nanoparticles (LNPs) CDMO Service Introduction
11.15.4 WuXi Biologics Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
11.15.5 WuXi Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Samsung Biologics
Hanmi Pharmaceutical
Catalent Biologics
FUJIFILM Pharmaceuticals
CordenPharma
eTheRNA
Esco Aster
Recipharm
Yuantai Biological Technology
GenScript Biotechnology
Wuxi Biologics
ST Pharm
Evonik
Lonza
Rentschler Biopharma
List of Tables
 Table 1. Global Lipid Nanoparticles (LNPs) CDMO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of mRNA-LNP CDMO
 Table 3. Key Players of siRNA-LNP CDMO
 Table 4. Key Players of pDNA-LNP CDMO
 Table 5. Key Players of Others
 Table 6. Global Lipid Nanoparticles (LNPs) CDMO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Lipid Nanoparticles (LNPs) CDMO Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Lipid Nanoparticles (LNPs) CDMO Service Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Lipid Nanoparticles (LNPs) CDMO Service Market Share by Region (2020-2025)
 Table 10. Global Lipid Nanoparticles (LNPs) CDMO Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Lipid Nanoparticles (LNPs) CDMO Service Market Share by Region (2026-2031)
 Table 12. Lipid Nanoparticles (LNPs) CDMO Service Market Trends
 Table 13. Lipid Nanoparticles (LNPs) CDMO Service Market Drivers
 Table 14. Lipid Nanoparticles (LNPs) CDMO Service Market Challenges
 Table 15. Lipid Nanoparticles (LNPs) CDMO Service Market Restraints
 Table 16. Global Lipid Nanoparticles (LNPs) CDMO Service Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Lipid Nanoparticles (LNPs) CDMO Service Market Share by Players (2020-2025)
 Table 18. Global Top Lipid Nanoparticles (LNPs) CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Nanoparticles (LNPs) CDMO Service as of 2024)
 Table 19. Ranking of Global Top Lipid Nanoparticles (LNPs) CDMO Service Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Lipid Nanoparticles (LNPs) CDMO Service Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Lipid Nanoparticles (LNPs) CDMO Service, Headquarters and Area Served
 Table 22. Global Key Players of Lipid Nanoparticles (LNPs) CDMO Service, Product and Application
 Table 23. Global Key Players of Lipid Nanoparticles (LNPs) CDMO Service, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Type (2020-2025)
 Table 27. Global Lipid Nanoparticles (LNPs) CDMO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Type (2026-2031)
 Table 29. Global Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Application (2020-2025)
 Table 31. Global Lipid Nanoparticles (LNPs) CDMO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Application (2026-2031)
 Table 33. North America Lipid Nanoparticles (LNPs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Lipid Nanoparticles (LNPs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Lipid Nanoparticles (LNPs) CDMO Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Lipid Nanoparticles (LNPs) CDMO Service Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Lipid Nanoparticles (LNPs) CDMO Service Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Lipid Nanoparticles (LNPs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Lipid Nanoparticles (LNPs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Lipid Nanoparticles (LNPs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Evonik Company Details
 Table 49. Evonik Business Overview
 Table 50. Evonik Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 51. Evonik Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 52. Evonik Recent Development
 Table 53. Lonza Company Details
 Table 54. Lonza Business Overview
 Table 55. Lonza Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 56. Lonza Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 57. Lonza Recent Development
 Table 58. Rentschler Biopharma Company Details
 Table 59. Rentschler Biopharma Business Overview
 Table 60. Rentschler Biopharma Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 61. Rentschler Biopharma Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 62. Rentschler Biopharma Recent Development
 Table 63. Samsung Biologics Company Details
 Table 64. Samsung Biologics Business Overview
 Table 65. Samsung Biologics Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 66. Samsung Biologics Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 67. Samsung Biologics Recent Development
 Table 68. Hanmi Pharmaceutical Company Details
 Table 69. Hanmi Pharmaceutical Business Overview
 Table 70. Hanmi Pharmaceutical Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 71. Hanmi Pharmaceutical Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 72. Hanmi Pharmaceutical Recent Development
 Table 73. Catalent Biologics Company Details
 Table 74. Catalent Biologics Business Overview
 Table 75. Catalent Biologics Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 76. Catalent Biologics Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 77. Catalent Biologics Recent Development
 Table 78. FUJIFILM Pharmaceuticals Company Details
 Table 79. FUJIFILM Pharmaceuticals Business Overview
 Table 80. FUJIFILM Pharmaceuticals Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 81. FUJIFILM Pharmaceuticals Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 82. FUJIFILM Pharmaceuticals Recent Development
 Table 83. CordenPharma Company Details
 Table 84. CordenPharma Business Overview
 Table 85. CordenPharma Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 86. CordenPharma Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 87. CordenPharma Recent Development
 Table 88. ST Pharm Company Details
 Table 89. ST Pharm Business Overview
 Table 90. ST Pharm Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 91. ST Pharm Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 92. ST Pharm Recent Development
 Table 93. eTheRNA Company Details
 Table 94. eTheRNA Business Overview
 Table 95. eTheRNA Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 96. eTheRNA Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 97. eTheRNA Recent Development
 Table 98. Esco Aster Company Details
 Table 99. Esco Aster Business Overview
 Table 100. Esco Aster Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 101. Esco Aster Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 102. Esco Aster Recent Development
 Table 103. Recipharm Company Details
 Table 104. Recipharm Business Overview
 Table 105. Recipharm Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 106. Recipharm Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 107. Recipharm Recent Development
 Table 108. Yuantai Biological Technology Company Details
 Table 109. Yuantai Biological Technology Business Overview
 Table 110. Yuantai Biological Technology Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 111. Yuantai Biological Technology Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 112. Yuantai Biological Technology Recent Development
 Table 113. GenScript Biotechnology Company Details
 Table 114. GenScript Biotechnology Business Overview
 Table 115. GenScript Biotechnology Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 116. GenScript Biotechnology Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 117. GenScript Biotechnology Recent Development
 Table 118. WuXi Biologics Company Details
 Table 119. WuXi Biologics Business Overview
 Table 120. WuXi Biologics Lipid Nanoparticles (LNPs) CDMO Service Product
 Table 121. WuXi Biologics Revenue in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025) & (US$ Million)
 Table 122. WuXi Biologics Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Lipid Nanoparticles (LNPs) CDMO Service Picture
 Figure 2. Global Lipid Nanoparticles (LNPs) CDMO Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lipid Nanoparticles (LNPs) CDMO Service Market Share by Type: 2024 VS 2031
 Figure 4. mRNA-LNP CDMO Features
 Figure 5. siRNA-LNP CDMO Features
 Figure 6. pDNA-LNP CDMO Features
 Figure 7. Others Features
 Figure 8. Global Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Lipid Nanoparticles (LNPs) CDMO Service Market Share by Application: 2024 VS 2031
 Figure 10. Vaccines and Drugs Case Studies
 Figure 11. Diagnostics and Medical Imaging Case Studies
 Figure 12. Nanotherapeutics Case Studies
 Figure 13. Others Case Studies
 Figure 14. Lipid Nanoparticles (LNPs) CDMO Service Report Years Considered
 Figure 15. Global Lipid Nanoparticles (LNPs) CDMO Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Lipid Nanoparticles (LNPs) CDMO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Lipid Nanoparticles (LNPs) CDMO Service Market Share by Region: 2024 VS 2031
 Figure 18. Global Lipid Nanoparticles (LNPs) CDMO Service Market Share by Players in 2024
 Figure 19. Global Top Lipid Nanoparticles (LNPs) CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Nanoparticles (LNPs) CDMO Service as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Lipid Nanoparticles (LNPs) CDMO Service Revenue in 2024
 Figure 21. North America Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Lipid Nanoparticles (LNPs) CDMO Service Market Share by Country (2020-2031)
 Figure 23. United States Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Lipid Nanoparticles (LNPs) CDMO Service Market Share by Country (2020-2031)
 Figure 27. Germany Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Lipid Nanoparticles (LNPs) CDMO Service Market Share by Region (2020-2031)
 Figure 35. China Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Lipid Nanoparticles (LNPs) CDMO Service Market Share by Country (2020-2031)
 Figure 43. Mexico Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Lipid Nanoparticles (LNPs) CDMO Service Market Share by Country (2020-2031)
 Figure 47. Turkey Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Lipid Nanoparticles (LNPs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Evonik Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 51. Lonza Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 52. Rentschler Biopharma Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 53. Samsung Biologics Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 54. Hanmi Pharmaceutical Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 55. Catalent Biologics Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 56. FUJIFILM Pharmaceuticals Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 57. CordenPharma Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 58. ST Pharm Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 59. eTheRNA Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 60. Esco Aster Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 61. Recipharm Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 62. Yuantai Biological Technology Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 63. GenScript Biotechnology Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 64. WuXi Biologics Revenue Growth Rate in Lipid Nanoparticles (LNPs) CDMO Service Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Lipid Nanoparticle CDMO Market Research Report 2025
Global Lipid Nanoparticle LNP Services Market Research Report 2025
Global Lipid Nanoparticle LNP Formulation Service Market Research Report 2025
Global RNA LNP Lipid Nanoparticle Formulation Market Research Report 2024
Global Lipid Nanoparticle LNP Synthesis Services Market Research Report 2025
Global Lipid Nanoparticle LNP Development Service Market Research Report 2025
Global Lipid Nanoparticle LNP Formulation Market Research Report 2024
Global Plasmid CDMO Services Market Research Report 2025
Global Mammalian CDMO Service Market Research Report 2024
Global Liposomal DDS Technology Market Research Report 2025
Global Lipid Nanoparticle Development Service Market Research Report 2024
Global Small Molecule Innovator CDMO Market Research Report 2025
Global Exosome CDMO Market Research Report 2024
Medical Device CDMO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Nanoparticle LNP Production Equipment Market Research Report 2024
Global Microbial CDMO Service Market Research Report 2024
Global Lipid Nanodiscs Market Research Report 2025
Small Molecule CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global LNP Synthesis System Market Research Report 2024
Global Lipid Nanoparticle LNP Raw Material Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions